Your browser doesn't support javascript.
loading
SARS-CoV-2-specific antibody and T-cell immunity in convalescents after infection wave in Beijing in late 2022.
Guan, Xuejiao; Huang, Qi; Dong, Mei; Li, Maozhong; Xie, Hui; Wei, Xiaofeng; Kang, Lu; Wang, Xue; Li, Aihua; Wang, Qing; Huang, Fang; Wang, Quanyi.
Afiliação
  • Guan X; Beijing Center for Disease Prevention and Control, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control Research and Prevention, Beijing 100013, People's Republic of China.
  • Huang Q; Beijing Center for Disease Prevention and Control, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control Research and Prevention, Beijing 100013, People's Republic of China; School of Public Health, Capital Medical University, Beijing 100069, People's Republic of China.
  • Dong M; Beijing Center for Disease Prevention and Control, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control Research and Prevention, Beijing 100013, People's Republic of China.
  • Li M; Beijing Center for Disease Prevention and Control, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control Research and Prevention, Beijing 100013, People's Republic of China.
  • Xie H; Beijing Center for Disease Prevention and Control, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control Research and Prevention, Beijing 100013, People's Republic of China.
  • Wei X; Beijing Center for Disease Prevention and Control, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control Research and Prevention, Beijing 100013, People's Republic of China; School of Public Health, Capital Medical University, Beijing 100069, People's Republic of China.
  • Kang L; Beijing Center for Disease Prevention and Control, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control Research and Prevention, Beijing 100013, People's Republic of China.
  • Wang X; Beijing Center for Disease Prevention and Control, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control Research and Prevention, Beijing 100013, People's Republic of China.
  • Li A; Beijing Center for Disease Prevention and Control, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control Research and Prevention, Beijing 100013, People's Republic of China.
  • Wang Q; Beijing Center for Disease Prevention and Control, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control Research and Prevention, Beijing 100013, People's Republic of China; School of Public Health, Capital Medical University, Beijing 100069, People's Republic of China.
  • Huang F; Beijing Center for Disease Prevention and Control, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control Research and Prevention, Beijing 100013, People's Republic of China; Beijing Research Center for Respiratory Infectious Diseases, People's Republic of China. Electron
  • Wang Q; Beijing Center for Disease Prevention and Control, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control Research and Prevention, Beijing 100013, People's Republic of China; Beijing Research Center for Respiratory Infectious Diseases, People's Republic of China. Electron
J Infect ; 87(5): 413-419, 2023 11.
Article em En | MEDLINE | ID: mdl-37652314
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Infect Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Infect Ano de publicação: 2023 Tipo de documento: Article